157 related articles for article (PubMed ID: 11955748)
1. Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy.
Harima Y; Sawada S; Nagata K; Sougawa M; Ohnishi T
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1345-51. PubMed ID: 11955748
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy.
Harima Y; Sawada S; Nagata K; Sougawa M; Ohnishi T
Int J Cancer; 2001 Oct; 96(5):286-96. PubMed ID: 11582581
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
[TBL] [Abstract][Full Text] [Related]
5. Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer.
Song YJ; Kim JY; Lee SK; Lim HS; Lim MC; Seo SS; Kang S; Lee DO; Park SY
Int J Cancer; 2011 Aug; 129(4):896-902. PubMed ID: 21064095
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
[TBL] [Abstract][Full Text] [Related]
7. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer.
Bachtiary B; Obermair A; Dreier B; Birner P; Breitenecker G; Knocke TH; Selzer E; Pötter R
Int J Cancer; 2002 Nov; 102(3):237-43. PubMed ID: 12397642
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
[TBL] [Abstract][Full Text] [Related]
9. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
[TBL] [Abstract][Full Text] [Related]
11. Human papilloma virus has no prognostic significance in cervical carcinoma.
Kristensen GB; Karlsen F; Jenkins A; Kaern J; Abeler VM; Tropé CG
Eur J Cancer; 1996 Jul; 32A(8):1349-53. PubMed ID: 8869098
[TBL] [Abstract][Full Text] [Related]
12. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy.
Nagai Y; Toma T; Moromizato H; Maehama T; Asato T; Kariya K; Kanazawa K
Am J Obstet Gynecol; 2004 Dec; 191(6):1907-13. PubMed ID: 15592271
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer.
Chen CA; Chen TM; Wu CC; Chang CF; Hsieh CY
J Cancer Res Clin Oncol; 1994; 120(11):678-82. PubMed ID: 7962045
[TBL] [Abstract][Full Text] [Related]
14. Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma.
Ikuta A; Saito J; Mizokami T; Nakamoto T; Yasuhara M; Nagata F; Nakajima M; Matsuo I; Yasuda K; Kanzaki H
Cancer Detect Prev; 2005; 29(6):528-36. PubMed ID: 16289387
[TBL] [Abstract][Full Text] [Related]
15. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
16. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.
Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY
J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372
[TBL] [Abstract][Full Text] [Related]
17. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
19. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of human papillomavirus and viral DNA load after radiotherapy for cervical carcinomas.
Kahla S; Kochbati L; Sarraj S; Ben Daya I; Maalej M; Oueslati R
Tumori; 2016 Oct; 102(5):521-526. PubMed ID: 26350192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
